Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

AKTX US Equity

Akari Therapeutics PlcHealth Care · Pharmaceutical Preparations · CIK 1541157 · FY ends Dec 31
$7.90
+0.00 (+0.01%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-1213GSchedule 13G filed — ≥5% beneficial owner (passive) · by BANK OF MONTREAL /CAN/sec.gov ↗
2026-08-0713GSchedule 13G filed — ≥5% beneficial owner (passive) · by White Lion Capital LLCsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-08-07

Every row is a filed document, checked against its EDGAR index.